Key hire
CEO, Kira Biotech
Dr Dan Baker
Roles
| Role | Organisation | Sources |
|---|---|---|
| CEO | Kira Biotech | OneVentures portfolio (Mon 3 Aug 2020), OneVentures portfolio (Mon 28 Oct 2019) |
| Vice President, Immunology (former) | Centocor/Janssen | OneVentures portfolio |
Coverage
Stories naming Dr Dan Baker. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Series A
$20m
Immunology Company Kira Biotech launches with $20M Series A Funding
Brisbane immunology company Kira Biotech has launched with a $20 million Series A, OneVentures leading alongside IP Group and Queensland government support, to progress its lead antibody KB312 into early human studies.
2 deals
US biotech heavyweights join OneVentures
OneVentures appoints Jim Scopa and Dan Baker to its healthcare investment team, and recalls its Healthcare Fund III backing Blade Therapeutics and BiVACOR.